Medication for Portal Hypertension - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Medication for Portal Hypertension Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Medication for Portal Hypertension Market Restraints
Table 3. Medication for Portal Hypertension Market Trends
Table 4. Medication for Portal Hypertension Industry Policy
Table 5. Global Medication for Portal Hypertension Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Medication for Portal Hypertension Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Medication for Portal Hypertension Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Medication for Portal Hypertension Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Medication for Portal Hypertension Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Medication for Portal Hypertension Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Medication for Portal Hypertension Mergers & Acquisitions, Expansion Plans
Table 12. Global Medication for Portal Hypertension Manufacturers Product Type
Table 13. Head Office and Medication for Portal Hypertension Production Site of Key Manufacturer
Table 14. Medication for Portal Hypertension Capacity of Major Manufacturers and Future Plan
Table 15. China Medication for Portal Hypertension Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Medication for Portal Hypertension Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Medication for Portal Hypertension Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Medication for Portal Hypertension Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Medication for Portal Hypertension Production by Region, 2018-2023, (K Units)
Table 20. Global Medication for Portal Hypertension Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Medication for Portal Hypertension Upstream (Raw Materials)
Table 22. Global Medication for Portal Hypertension Typical Customers
Table 23. Medication for Portal Hypertension Typical Distributors
Table 24. By Type, Global Medication for Portal Hypertension Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Medication for Portal Hypertension Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Medication for Portal Hypertension Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Medication for Portal Hypertension Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Medication for Portal Hypertension Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Medication for Portal Hypertension Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Medication for Portal Hypertension Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Medication for Portal Hypertension Sales Quantity Market Share, 2018-2029
Table 34. Genextra S.p.a. Company Information, Head Office, Market Area, and Industry Position
Table 35. Genextra S.p.a. Medication for Portal Hypertension Models, Specifications, and Application
Table 36. Genextra S.p.a. Medication for Portal Hypertension Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Genextra S.p.a. Company Profile and Main Business
Table 38. Genextra S.p.a. Recent Developments
Table 39. Sun Pharmaceuticals Industries Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 40. Sun Pharmaceuticals Industries Ltd. Medication for Portal Hypertension Models, Specifications, and Application
Table 41. Sun Pharmaceuticals Industries Ltd. Medication for Portal Hypertension Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Sun Pharmaceuticals Industries Ltd. Company Profile and Main Business
Table 43. Sun Pharmaceuticals Industries Ltd. Recent Developments
Table 44. Chiasma Inc Company Information, Head Office, Market Area, and Industry Position
Table 45. Chiasma Inc Medication for Portal Hypertension Models, Specifications, and Application
Table 46. Chiasma Inc Medication for Portal Hypertension Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Chiasma Inc Company Profile and Main Business
Table 48. Chiasma Inc Recent Developments
Table 49. Ono Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 50. Ono Pharmaceutical Co., Ltd. Medication for Portal Hypertension Models, Specifications, and Application
Table 51. Ono Pharmaceutical Co., Ltd. Medication for Portal Hypertension Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Ono Pharmaceutical Co., Ltd. Company Profile and Main Business
Table 53. Ono Pharmaceutical Co., Ltd. Recent Developments
Table 54. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 55. Novartis AG Medication for Portal Hypertension Models, Specifications, and Application
Table 56. Novartis AG Medication for Portal Hypertension Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Novartis AG Company Profile and Main Business
Table 58. Novartis AG Recent Developments
Table 59. Dr. Falk Pharma GmbH Company Information, Head Office, Market Area, and Industry Position
Table 60. Dr. Falk Pharma GmbH Medication for Portal Hypertension Models, Specifications, and Application
Table 61. Dr. Falk Pharma GmbH Medication for Portal Hypertension Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Dr. Falk Pharma GmbH Company Profile and Main Business
Table 63. Dr. Falk Pharma GmbH Recent Developments
Table 64. Gilead Sciences Inc. Company Information, Head Office, Market Area, and Industry Position
Table 65. Gilead Sciences Inc. Medication for Portal Hypertension Models, Specifications, and Application
Table 66. Gilead Sciences Inc. Medication for Portal Hypertension Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Gilead Sciences Inc. Company Profile and Main Business
Table 68. Gilead Sciences Inc. Recent Developments
Table 69. United Therapeutics Corporation Company Information, Head Office, Market Area, and Industry Position
Table 70. United Therapeutics Corporation Medication for Portal Hypertension Models, Specifications, and Application
Table 71. United Therapeutics Corporation Medication for Portal Hypertension Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. United Therapeutics Corporation Company Profile and Main Business
Table 73. United Therapeutics Corporation Recent Developments
Table 74. Debiovision, Inc. Company Information, Head Office, Market Area, and Industry Position
Table 75. Debiovision, Inc. Medication for Portal Hypertension Models, Specifications, and Application
Table 76. Debiovision, Inc. Medication for Portal Hypertension Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Debiovision, Inc. Company Profile and Main Business
Table 78. Debiovision, Inc. Recent Developments
List of Figures
Figure 1. Medication for Portal Hypertension Picture
Figure 2. Global Medication for Portal Hypertension Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Medication for Portal Hypertension Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Medication for Portal Hypertension Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Medication for Portal Hypertension Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Medication for Portal Hypertension Sales Quantity (K Units) & (2018-2029)
Figure 7. China Medication for Portal Hypertension Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Medication for Portal Hypertension Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Medication for Portal Hypertension Market Share of Global, 2018-2029
Figure 10. Global Medication for Portal Hypertension Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Medication for Portal Hypertension Key Participants, Market Share, 2022
Figure 12. Global Medication for Portal Hypertension Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Medication for Portal Hypertension Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Medication for Portal Hypertension Production Market Share & Forecast by Region, 2018-2029
Figure 15. Medication for Portal Hypertension Industry Chain
Figure 16. Medication for Portal Hypertension Procurement Model
Figure 17. Medication for Portal Hypertension Sales Model
Figure 18. Medication for Portal Hypertension Sales Channels, Direct Sales, and Distribution
Figure 19. Beta-Blockers
Figure 20. Vasodilators
Figure 21. Lactulose
Figure 22. Antibiotics
Figure 23. Diuretics
Figure 24. By Type, Global Medication for Portal Hypertension Consumption Value, 2018-2029, US$ Million
Figure 25. By Type, Global Medication for Portal Hypertension Consumption Value Market Share, 2018-2029
Figure 26. By Type, Global Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Figure 27. By Type, Global Medication for Portal Hypertension Sales Quantity Market Share, 2018-2029
Figure 28. By Type, Global Medication for Portal Hypertension Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 29. Hospital
Figure 30. Specialist Clinic
Figure 31. Others
Figure 32. By Application, Global Medication for Portal Hypertension Consumption Value, 2018-2029, US$ Million
Figure 33. By Application, Global Medication for Portal Hypertension Consumption Value Market Share, 2018-2029
Figure 34. By Application, Global Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Figure 35. By Application, Global Medication for Portal Hypertension Sales Quantity Market Share, 2018-2029
Figure 36. By Application, Global Medication for Portal Hypertension Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 37. By Region, Global Medication for Portal Hypertension Consumption Value Market Share, 2018-2029
Figure 38. By Region, Global Medication for Portal Hypertension Sales Quantity Market Share, 2018-2029
Figure 39. North America Medication for Portal Hypertension Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Medication for Portal Hypertension Consumption Value Market Share, 2022
Figure 41. Europe Medication for Portal Hypertension Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Medication for Portal Hypertension Consumption Value Market Share, 2022
Figure 43. Asia Pacific Medication for Portal Hypertension Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Medication for Portal Hypertension Consumption Value Market Share, 2022
Figure 45. South America Medication for Portal Hypertension Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Medication for Portal Hypertension Consumption Value Market Share, 2022
Figure 47. Middle East & Africa Medication for Portal Hypertension Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, U.S. Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, Europe Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 54. China Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, China Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, China Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 57. Japan Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, Japan Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, Japan Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 60. South Korea Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, South Korea Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, South Korea Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 63. Southeast Asia Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, Southeast Asia Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, Southeast Asia Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 66. India Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, India Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, India Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 69. Middle East & Africa Medication for Portal Hypertension Sales Quantity, 2018-2029, (K Units)
Figure 70. By Type, Middle East & Africa Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, Middle East & Africa Medication for Portal Hypertension Sales Quantity Market Share, 2022 VS 2029
Figure 72. Research Methodology
Figure 73. Breakdown of Primary Interviews
Figure 74. Bottom-up and Top-down Approaches
Figure 75. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets